Past Contracts

Previous years' contract solicitations can be viewed here: 

• Fiscal year 2016 Program Solicitation Public Health Service
• Fiscal Year 2015 SBIR Program Solicitation Public Health Service
• Fiscal Year 2014 SBIR Program Solicitaion Public Health Service
• Fiscal Year 2013 SBIR Program Solicitaion Public Health Service

PHS2016 included 14 contract topics released by NCI:

• 341 - Development of Metabolomics Data Integration Methods and Software
• 342 - Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention
• 343 - An Electronic Platform for Cognitive Assessment in Cancer Patients
• 344 - Technologies for Differential Isolation of Exosomes and Oncosomes
• 345 - Predictive Biomarkers of Adverse Reactions to Radiation Treatment
• 346 - Molecularly Targeted Radiation Therapy For Cancer Treatment
• 347 - Signal Amplification to Enable Attomolar Quantitation in Slide-Based or ELISA Biomarker Immunoassays
• 348 - Identification and Capture of Enriched Tumor Zones with Preservation of Labile Biomarkers from Ultra-Cold Biopsies
• 349 - Proximity Slide Based Sandwich Immunoassay to Visualize Intramolecular Epitopes of Analytes in Tissue Sections
• 350 - Highly Innovative Tools for Quantifying Redox Effector Dynamics in Cancer
• 351 - Modulating the Microbiome to Improve Efficacy of Cancer Therapeutics
• 352 - Cell and Animal-Based Models to Advance Cancer Health Disparity Research
• 353 - Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis
• 354 - Companion Diagnostics for Cancer Immunotherapies

PHS2015 included 7 contract topics released by NCI:

• 334 - Vacutubes to Preserve the Viability of Circulating Tumor Cells
• 335 - Development of Advanced Culture Systems for Expansion of Cancer Stem Cells
• 336 - Development of Novel Therapeutic Agents That Target Cancer Stem Cells
• 337 - Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis
• 338 - Predictive Biomarkers of Adverse Reactions to Radiation Treatment
• 339 - Systemic Targeted Radionuclide Therapy For Cancer Treatment
• 340 - Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention

PHS2014 included 8 contract topics released by NCI:

• 326 - Development of Novel Therapeutic Agents that Target Cancer Stem Cells
• 327 - Reformulation of Failed Chemotherapeutic Drugs
  • Click here for answers to frequently asked questions on contract topic 327 
• 328 - Validation of 3D Human Tissue Culture Systems that Mimic the Tumor Microenvironment
• 329 - Proteomic Analysis of Single Cells Isolated from Solid Tumors
• 330 - Generation of Site-Specific Phospho-Threonine Protein Standards for use in Cancer Assays
• 331 - Development of a Biosensor-Based Core Needle Tumor Biopsy Device
• 332 - Development of Radiation Modulators for Use During Radiotherapy
  • Click here for answers to frequently asked questions on contract topic 332
• 333 - Software Tools for the Development of Environmental Measures Related to Cancer Health Behaviors and Resources

PHS2013 included 13 contract topics released by NCI: